120287-30-1 Usage
Uses
Used in Research and Laboratory Settings:
8-bromo-6-nitroquinoline is used as a building block for the synthesis of other organic compounds, facilitating the creation of a wide range of chemical entities for various applications.
Used in the Production of Dyes:
8-bromo-6-nitroquinoline is used as a precursor in the production of dyes, capitalizing on its red-brown color to contribute to the coloration of various products.
Used in Pharmaceutical Industry:
8-bromo-6-nitroquinoline is used as an intermediate in the synthesis of pharmaceuticals, potentially contributing to the development of new drugs.
Used in Agrochemicals:
8-bromo-6-nitroquinoline is used in the formulation of agrochemicals, possibly for its role in the development of pesticides or other agricultural chemicals.
Used in Anticancer Research:
8-bromo-6-nitroquinoline is used as a potential anti-cancer agent in research settings, where it has shown promising activity in inhibiting the growth of cancer cells.
The potential toxicological effects and environmental impacts of 8-bromo-6-nitroquinoline are ongoing areas of research, indicating a need for careful consideration in its application and handling.
Check Digit Verification of cas no
The CAS Registry Mumber 120287-30-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,2,8 and 7 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 120287-30:
(8*1)+(7*2)+(6*0)+(5*2)+(4*8)+(3*7)+(2*3)+(1*0)=91
91 % 10 = 1
So 120287-30-1 is a valid CAS Registry Number.
120287-30-1Relevant articles and documents
QUINOLINES AS FGFR KINASE MODULATORS
-
Page/Page column 147, (2013/05/21)
The invention relates to new quinoline derivative compounds of formula (I), to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. ca
INHIBITORS OF BRUTON'S TYROSINE KINASE
-
Paragraph 0262; 0263, (2013/06/27)
This application discloses compounds according to generic Formula I: wherein the variables are defined as described herein, and which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with
BROMINATION OF QUINOLINE DERIVATIVES WITH N-BROMOSUCCINIMIDE. ISOMERIC COMPOSITION OF THE BROMINATION PRODUCTS BY PMR AND GLC
Tochilkin, A. I.,Kovel'man, I. R.,Prokof'ev, E. P.,Gracheva, I. N.,Levinskii, M. V.
, p. 892 - 897 (2007/10/02)
The bromination of quinoline and substituted quinolines with N-bromosuccinimide in concentrated H2SO4 takes place exclusively in the homocyclic part.Bromo-substituted quinolines can be obtained by this method.The bromination products were identified by PMR spectroscopy.The differences among the mono-, di-, and trisubstituted (in the benzene ring) compounds were established on the basis of the type of spectrum of the protons of the homocyclic part of the molecule.The compositions of the reaction mixtures were studied by GLC.